Home › NDC Lookup › RxCUI directory › RxCUI 2734142

Acyclovir 0.03 MG/MG Ophthalmic Ointment [Avaclyr] — RxCUI 2734142

RxNorm drug concept · Semantic branded drug
RxCUI 2734142 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2734142
Official nameAcyclovir 0.03 MG/MG Ophthalmic Ointment [Avaclyr]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAvaclyr 3 % Ophthalmic Ointment; acycycloguanosine 0.03 MG/MG Ophthalmic Ointment [Avaclyr]; Avaclyr 0.03 MG/MG Ophthalmic Ointment
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acyclovir Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Acyclovir cream is used to treat cold sores — those small, painful blisters that appear on or around the lips, caused by the herpes simplex virus. It's approved for adults and teen...
  • What exactly is acyclovir cream used for?
  • The sooner the better — ideally at the very first tingle or sign of a cold sore coming on. For the ointment form, the standard schedule is every 3 hours, 6 times a day, for 7 days....
  • When should I start applying it, and how often?
📖 Read our full Acyclovir Topical guide →

🕸️ Concept Web — How Acyclovir 0.03 MG/MG Ophthalmic Ointment [Avacly... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acyclovir 0.03 MG/MG Ophthalmic Ointment [Avaclyr] RxCUI 2734142

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Acyclovir 281
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Avaclyr 2734138
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acyclovir Ophthalmic Ointment 376437
    • Acyclovir Ophthalmic Product 1153459
    • Acyclovir Ophthalmic Ointment [Avaclyr] 2734141
    • Avaclyr Ophthalmic Product 2734140
    • Ophthalmic Ointment 91344
    • Ophthalmic Product 1151135
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Acyclovir 0.03 MG/MG [Avaclyr] SBDC · 2734139
  • Acyclovir Ophthalmic Ointment [Avaclyr] SBDF · 2734141
  • Avaclyr Ophthalmic Product SBDG · 2734140
  • Avaclyr BN · 2734138

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2734142 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
48102-0028-35 1 TUBE in 1 CARTON (48102-028-35) / 3.5 g in 1 TUBE Avaclyr Fera Pharmaceuticals, LLC 2026-01-31
Observed labelers: Fera Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.